Tandem Diabetes Care (TNDM) Competitors

ICU Medical (NASDAQ:ICUI) and Tandem Diabetes Care (NASDAQ:TNDM) are both mid-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, valuation, media sentiment, dividends, analyst recommendations, community ranking, institutional ownership and profitability.

Do analysts rate ICUI or TNDM?

ICU Medical presently has a consensus target price of $123.00, indicating a potential upside of 23.01%. Tandem Diabetes Care has a consensus target price of $43.45, indicating a potential downside of 2.83%. Given Tandem Diabetes Care's stronger consensus rating and higher probable upside, equities research analysts clearly believe ICU Medical is more favorable than Tandem Diabetes Care.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ICU Medical	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
Tandem Diabetes Care	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.64

Does the MarketBeat Community prefer ICUI or TNDM?

Tandem Diabetes Care received 184 more outperform votes than ICU Medical when rated by MarketBeat users. However, 64.48% of users gave ICU Medical an outperform vote while only 60.97% of users gave Tandem Diabetes Care an outperform vote.

Company	Underperform	Outperform
ICU Medical	Outperform Votes 383 64.48%	Underperform Votes 211 35.52%
Tandem Diabetes Care	Outperform Votes 567 60.97%	Underperform Votes 363 39.03%

Do insiders & institutionals believe in ICUI or TNDM?

96.1% of ICU Medical shares are held by institutional investors. 6.7% of ICU Medical shares are held by company insiders. Comparatively, 2.2% of Tandem Diabetes Care shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Is ICUI or TNDM more profitable?

ICU Medical has a net margin of -1.31% compared to ICU Medical's net margin of -18.37%. Tandem Diabetes Care's return on equity of 6.35% beat ICU Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ICU Medical	-1.31%	6.35%	3.03%
Tandem Diabetes Care	-18.37%	-32.33%	-10.90%

Which has more risk and volatility, ICUI or TNDM?

ICU Medical has a beta of 0.72, indicating that its share price is 28% less volatile than the S&P 500. Comparatively, Tandem Diabetes Care has a beta of 1.1, indicating that its share price is 10% more volatile than the S&P 500.

Does the media favor ICUI or TNDM?

In the previous week, Tandem Diabetes Care had 18 more articles in the media than ICU Medical. MarketBeat recorded 23 mentions for Tandem Diabetes Care and 5 mentions for ICU Medical. ICU Medical's average media sentiment score of 1.14 beat Tandem Diabetes Care's score of 0.60 indicating that Tandem Diabetes Care is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
ICU Medical	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Tandem Diabetes Care	14 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has higher valuation and earnings, ICUI or TNDM?

ICU Medical has higher revenue and earnings than Tandem Diabetes Care. ICU Medical is trading at a lower price-to-earnings ratio than Tandem Diabetes Care, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ICU Medical	$2.26B	1.08	-$29.66M	-$1.23	-81.29
Tandem Diabetes Care	$747.72M	3.86	-$222.61M	-$2.17	-20.61

Summary

ICU Medical beats Tandem Diabetes Care on 11 of the 18 factors compared between the two stocks.